Skip to main navigation Skip to search Skip to main content

Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma

  • Rainer Hamacher
  • , Helena Lanzafame
  • , Ilektra A. Mavroeidi
  • , Kim M. Pabst
  • , Lukas Kessler
  • , Phyllis F. Cheung
  • , Sebastian Bauer
  • , Ken Herrmann
  • , Hans Ulrich Schildhaus
  • , Jens T. Siveke
  • , Wolfgang P. Fendler
  • University Hospital of Essen
  • German Cancer Research Center

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations
Original languageEnglish
Pages (from-to)361-367
Number of pages7
JournalPET Clinics
Volume18
Issue number3
DOIs
StatePublished - Jul 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • FAP-Alpha
  • FAPI
  • Oncology
  • PET
  • Radioligand
  • Sarcoma
  • Therapy

Cite this